Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 16.73
+0.07 (0.42%)
Jul 10, 2026, 4:08 PM HKT
Sinopharm Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 52,209 | 60,666 | 66,470 | 63,817 | 61,914 | 52,926 | |
Market Cap Growth | -9.08% | -8.73% | 4.16% | 3.08% | 16.98% | -10.07% |
Enterprise Value | 154,917 | 163,857 | 178,877 | 158,985 | 148,432 | 150,328 |
Last Close Price | 16.73 | 18.50 | 19.49 | 17.90 | 16.76 | 13.68 |
PE Ratio | 6.49 | 7.62 | 8.86 | 6.40 | 6.42 | 5.56 |
Forward PE | 5.80 | 6.85 | 7.01 | 5.82 | 6.05 | 4.93 |
PS Ratio | 0.08 | 0.10 | 0.11 | 0.10 | 0.10 | 0.08 |
PB Ratio | 0.34 | 0.41 | 0.49 | 0.48 | 0.50 | 0.43 |
P/TBV Ratio | 0.60 | 0.72 | 0.89 | 0.90 | 0.95 | 0.84 |
P/FCF Ratio | 3.12 | 4.31 | 6.20 | 3.81 | 2.91 | 5.96 |
P/OCF Ratio | 2.83 | 3.86 | 5.41 | 3.37 | 2.61 | 4.63 |
PEG Ratio | 1.44 | 1.50 | 0.87 | 0.58 | 0.43 | 0.43 |
EV/Sales Ratio | 0.24 | 0.26 | 0.29 | 0.24 | 0.24 | 0.24 |
EV/EBITDA Ratio | 6.08 | 7.64 | 8.42 | 5.91 | 5.30 | 5.35 |
EV/EBIT Ratio | 7.42 | 8.55 | 9.43 | 6.47 | 5.77 | 5.84 |
EV/FCF Ratio | 9.26 | 11.65 | 16.68 | 9.49 | 6.97 | 16.93 |
Debt / Equity Ratio | 0.56 | 0.53 | 0.60 | 0.61 | 0.63 | 0.69 |
Debt / EBITDA Ratio | 3.58 | 3.33 | 3.42 | 2.78 | 2.60 | 2.76 |
Debt / FCF Ratio | 5.15 | 5.61 | 7.58 | 4.85 | 3.69 | 9.45 |
Net Debt / Equity Ratio | 0.29 | 0.14 | 0.15 | 0.06 | 0.10 | 0.22 |
Net Debt / EBITDA Ratio | 2.06 | 1.01 | 0.95 | 0.27 | 0.45 | 0.96 |
Net Debt / FCF Ratio | 2.68 | 1.54 | 1.88 | 0.44 | 0.59 | 3.04 |
Asset Turnover | 1.41 | 1.47 | 1.51 | 1.60 | 1.58 | 1.61 |
Inventory Turnover | 8.03 | 8.49 | 8.83 | 9.06 | 8.98 | 9.68 |
Quick Ratio | 1.10 | 1.07 | 1.06 | 1.06 | 0.99 | 1.01 |
Current Ratio | 1.40 | 1.41 | 1.39 | 1.40 | 1.36 | 1.33 |
Return on Equity (ROE) | 8.11% | 8.31% | 8.44% | 13.03% | 13.68% | 13.78% |
Return on Assets (ROA) | 2.63% | 2.75% | 2.87% | 3.73% | 4.06% | 4.06% |
Return on Invested Capital (ROIC) | 7.59% | 8.43% | 9.74% | 13.84% | 14.48% | 14.19% |
Return on Capital Employed (ROCE) | 11.70% | 12.00% | 12.50% | 15.70% | 17.50% | 18.10% |
Earnings Yield | 15.48% | 13.13% | 11.29% | 15.63% | 15.57% | 17.99% |
FCF Yield | 32.04% | 23.19% | 16.13% | 26.26% | 34.39% | 16.78% |
Dividend Yield | 4.77% | 4.15% | 3.71% | 5.36% | 5.53% | 6.73% |
Payout Ratio | 28.21% | 29.66% | 38.51% | 28.26% | 27.45% | 27.75% |
Buyback Yield / Dilution | -0.24% | - | - | -0.12% | 0.12% | -0.30% |
Total Shareholder Return | 4.53% | 4.15% | 3.71% | 5.24% | 5.65% | 6.43% |